TAMs, through expressing heme oxygenase-1 (HO-1), an enzyme that inhibits immune system, suppress the endothelial cells’ response to tumor necrosis factor-a (TNFα), an immunogenic cytokine, and then maintain the immunosuppressive tumor microenvironment (29). Here, TNF is linked to neoplasm.